Human Papillomavirus Vaccination Estimates Among Adolescents in the Mississippi Delta Region: National Immunization Survey ‑Teen, 2015-2017
(Source: CDC Preventing Chronic Disease)
Source: CDC Preventing Chronic Disease - April 16, 2020 Category: International Medicine & Public Health Tags: Public Health Source Type: news
Trends in Incidence of Cancers of the Oral Cavity and Pharynx --- United States 2007--2016
From 2007 to 2016, incidence of cancers of the oral cavity and pharynx combined increased. The increase could be driven by increases in human papillomavirus-associated cancers. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - April 16, 2020 Category: American Health Tags: Cancer HPV-Associated Cancers MMWR Morbidity & Mortality Weekly Report Oral Cancer Source Type: news
HPV Viral Load and Long-Term Survival in Cervical Cancer HPV Viral Load and Long-Term Survival in Cervical Cancer
This study investigated the association of high-risk human papillomavirus viral load and prognosis of patients with cervical cancer. How does a high viral load impact therapeutic response?American Journal of Clinical Pathology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 14, 2020 Category: Consumer Health News Tags: Pathology & Lab Medicine Journal Article Source Type: news
Therapeutic HPV vaccine may improve outcomes in advanced cervical cancer
(American Association for the Advancement of Science) Combining a therapeutic vaccine for human papilloma virus (HPV) with two standard chemotherapy drugs may extend survival in patients with advanced, recurrent cervical cancer, according to a phase 1/2 trial involving 77 patients. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 18, 2020 Category: Cancer & Oncology Source Type: news
Race, Insurance Status Linked to Lower Cancer Survival
MONDAY, March 16, 2020 -- Nonwhite, uninsured patients with clinically favorable human papillomavirus (HPV)-associated squamous cell carcinoma of the head and neck (SCCHN) have higher mortality than their white peers, according to a study published... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 16, 2020 Category: Pharmaceuticals Source Type: news
Exploring Opportunities to Leverage Pharmacists in Rural Areas to Promote Administration of Human Papillomavirus Vaccine
(Source: CDC Preventing Chronic Disease)
Source: CDC Preventing Chronic Disease - March 12, 2020 Category: International Medicine & Public Health Tags: Public Health Source Type: news
HPV infections can be eliminated if both boys and girls are vaccinated
(Karolinska Institutet) The human papillomavirus (HPV) causes, amongst other diseases, cancer of the cervix and oropharynx. A Swedish-Finnish study published in The Journal of Infectious Diseases now shows that the most oncogenic HPV types can be eliminated, but only if both girls and boys are vaccinated. Both genders will be offered vaccination in Sweden as of 2020. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 12, 2020 Category: Cancer & Oncology Source Type: news
Roche receives FDA approval for CINtec PLUS Cytology test to aid clinicians in improving cervical cancer prevention
Basel, 11 March 2020 — Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced US Food and Drug Administration (FDA) approval of CINtec®PLUS Cytology as the first biomarker-based triage test for women whose primary cervical cancer screening results are positive for the human papillomavirus (HPV) using the cobas ® 4800 HPV Test. This biomarker technology simplifies clinical decision making by providing easy to understand results so that clinicians and women are clear on next steps. (Source: Roche Investor Update)
Source: Roche Investor Update - March 11, 2020 Category: Pharmaceuticals Source Type: news
Roche receives FDA approval for CINtec PLUS Cytology test to aid clinicians in improving cervical cancer prevention
Basel, 11 March 2020 — Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced US Food and Drug Administration (FDA) approval of CINtec®PLUS Cytology as the first biomarker-based triage test for women whose primary cervical cancer screening results are positive for the human papillomavirus (HPV) using the cobas ® 4800 HPV Test. This biomarker technology simplifies clinical decision making by providing easy to understand results so that clinicians and women are clear on next steps. The CINtecPLUS Cytology test identifies those women whose HPV infections are most likely to be associated with cervical pre-cancers. It enables c...
Source: Roche Media News - March 11, 2020 Category: Pharmaceuticals Source Type: news
HPV Tied to Miscarriages and Preterm Births HPV Tied to Miscarriages and Preterm Births
Pregnant women infected with human papillomavirus (HPV) may be at increased risk for miscarriages and preterm deliveries, a review of past research suggests.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 3, 2020 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news
HPV Biomarkers Linked to Improved Survival With Esophageal Dysplasia, Adenocarcinoma HPV Biomarkers Linked to Improved Survival With Esophageal Dysplasia, Adenocarcinoma
Human papillomavirus (HPV) positivity and HPV biomarkers are associated with improved survival in adults with Barrett high-grade dysplasia (HGD) and esophageal adenocarcinoma (EAC), according to a new study.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 21, 2020 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Gay Men Underestimate Their Risks From HPV
THURSDAY, Feb. 20, 2020 -- Young men who have sex with other men don ' t fully grasp their risk for human papillomavirus (HPV) infection, due to a lack of information from health care providers, researchers say.
Interviews with men in their early 20s... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 20, 2020 Category: General Medicine Source Type: news
Young men unaware of risks of HPV infection and need for HPV vaccination
(Rutgers University) Young sexual minority men -- including those who are gay, bisexual, queer or straight-identified men who have sex with men -- do not fully understand their risk for human papillomavirus (HPV) due to a lack of information from health care providers, according to Rutgers researchers. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 11, 2020 Category: International Medicine & Public Health Source Type: news
One HPV Vaccine Dose May Be As Effective As Multiple, Study Finds
BOSTON (CBS) — It is currently recommended that boys and girls under age 15 get two doses of the human papillomavirus (HPV) vaccine but a new study published in the journal Cancer finds that just one dose may be as effective.
HPV is the most common sexually transmitted infection and certain strains of the virus are associated with cervical cancer in women.
Researchers at the University of Texas looked at more than 130,000 females and found that one dose of the HPV vaccine was as effective as multiple doses for preventing cervical changes that often lead to cervical cancer.
The hope is that if only one dose is require...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - February 10, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Healthwatch Seen On WBZ-TV Syndicated CBSN Boston Syndicated Local Dr. Mallika Marshall HPV vaccine Source Type: news
Single Dose of HPV Vaccine May Cut Preinvasive Cervical Disease
MONDAY, Feb. 10, 2020 -- Receipt of one, two, or three doses of the human papillomavirus (HPV) vaccine among females aged 15 to 19 years is associated with reduced incidence of preinvasive cervical disease at five years compared to that seen in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 10, 2020 Category: Pharmaceuticals Source Type: news
